Background
malaria, IRD
INFECTIOUS DISEASES, MALARIA
Edited by: Adrian John Frederick Luty, Institut de Recherche Pour le Développement (IRD), FranceReviewed by: Takashi Imai, National Institute of Infectious Diseases (NIID), Japan; Prakash Srinivasan, Johns Hopkins University, United States; Sean Yanik, Johns Hopkins University, United States, in collaboration with reviewer PS†Present addresses: Sachiko Ezoe, Medical Division, Nobelpharma Co., Ltd., Tokyo, Japan; Takanobu Sato, Plusultra pharma GmbH, Duesseldorf, Germany; Odile Leroy, Sorekara-x consultant, Garches, France‡These authors have contributed equally to this work and share first authorship§These authors have contributed equally to this work‖These authors have contributed equally to this work and share last authorshipBK-SE36/CpG is a recombinant blood-stage malaria vaccine candidate based on the N-terminal 